← Leaderboards
Siobhan Pattwell
Seattle Children'S Hospital
$636,768
Attributed
$636,768
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $262.7K · FY2021–23$500K$375K$250K$125K$0
'21
'22
'23
Funding mix
By agency
NIH$636,768 · 1
By mechanism
K22$636,768 · 1
Top collaborators
No co-investigators on record.
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- Stefan H.i. Kappe$29,220,139
- Laura A Jansen$3,196,617
- Shaun William Jackson$9,327,534
- Kai Yu$560,088
- Stephanie Bonney$639,076
Others in their field
Other Emerging Leaders on “In Vivo”
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
- John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
- Tony Moody · Duke University$34,777,314
- Alan D. Palkowitz · Indiana University Indianapolis$18,925,366
Research focus
In VivoMaintenanceAutomobile DrivingIn VitroAntibodiesLinkCancer InitiationCancer TypeAnatomyIndexingCombinatorialBiologyCancer EtiologyDiagnosticEmbryoEmbryonic DevelopmentErinaceidaeEventExperimental StudyCareerCellsAlternative SplicingGliomaMalignant Neoplasms
Grant awards (4)
Characterizing an alternatively spliced NTRK2 isoform in development and cancer$187,056
K22 · FY2023 · CA · contact PI
Characterizing an alternatively spliced NTRK2 isoform in development and cancer$75,600
K22 · FY2023 · CA · contact PI
Characterizing an alternatively spliced NTRK2 isoform in development and cancer$187,056
K22 · FY2022 · CA · contact PI
Characterizing an alternatively spliced NTRK2 isoform in development and cancer$187,056
K22 · FY2021 · CA · contact PI